AKTS
Aktis Oncology, Inc.
Set alert
15.93 USD -0.92 -5.46%
15.77 Day range 17.03
15.06 52-week range 32.23
- YTD
- -28.88%
- 1 year
- -28.88%
- Open
- 17.03
- Prev close
- 16.85
- Mkt cap
- 886.02M
- Vol
- 251.54K
- Avg vol
- 361.91K
- EPS
- -1.70
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 15.77
- High
- 17.03
- Forward P/E
- -8.45
- Beta
- 0.00
- Short ratio
- 10.89
- Inst. own
- 73.01%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 12, 2026
- 50-d avg
- 22.96
- 200-d avg
- 21.42
- 1y target
- 35.39
1Y chart
Closing price and volume
Compare AKTS
Chart and line up AKTS against other symbols or a saved comparison set.
- AKTS Aktis Oncology, Inc.
15.93
-0.92 -5.46%
- SPY State Street SPDR S&P 500 ETF Trust
755.72
-13.64 -1.77%
- QQQ Invesco QQQ Trust
690.49
-24.85 -3.47%
Sign in to keep these symbols in a saved comparison set.
| Metric | AKTS | SPY | QQQ |
|---|---|---|---|
| Last price | 15.93 | 755.72 | 690.49 |
| Change | -0.92 | -13.64 | -24.85 |
| Change % | -5.46% | -1.77% | -3.47% |
| Open | 17.03 | 761.38 | 697.13 |
| Day high | 17.03 | 761.46 | 698.63 |
| Day low | 15.77 | 750.36 | 683.45 |
| Previous close | 16.85 | 769.36 | 715.34 |
| Volume | 251.54K | 77.70M | 85.24M |
| Average volume | 361.91K | 41.22M | 34.57M |
| Market cap | 886.02M | 812.08B | 483.28B |
| P/E ratio | 0.00 | 23.99 | 26.44 |
| Earnings per share | -1.70 | 31.50 | 26.12 |
| Dividend yield | 0.00 | 0.00 | 0.00 |
| 52-week high | 32.23 | 779.09 | 759.66 |
| 52-week low | 15.06 | 631.97 | 558.28 |
| 1-week return | +1.27% | -0.559233% | -1.97% |
| 1-month return | -18.18% | -0.906075% | -6.66% |
| 3-month return | -30.74% | +1.89% | +1.02% |
| 6-month return | -15.04% | +5.16% | +3.41% |
| Year-to-date return | -28.88% | +10.82% | +12.40% |
| 1-year return | -28.88% | +11.16% | +10.29% |
| 2-year return | -28.88% | +32.90% | +42.71% |
| 50-day moving average | 20.73 | 767.63 | 725.41 |
| 200-day moving average | 21.04 | 728.53 | 679.17 |
| Target price | 35.39 | — | — |
| Beta | 0.00 | 0.00 | 0.00 |
| Short ratio | 10.89 | — | — |
| Institutional ownership | 73.01% | — | — |